Summary of Product Characteristics
last updated on the eMC:
17/09/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 17/09/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 12/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Use of sanofi aventis trading style
|
|
Updated on 10/08/2006 and displayed until 17/09/2007
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MA number
-
Change to section 10 (date of (partial) revision of the text
|
| Date of revision of text on the SPC: 07/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 7: Change to Marketing Authorisation Holder to: Aventis Pharma Limited, 50 Kings Hill Avenue, Kings Hill, West Malling, Kent, ME19 4AH
Section 8: change to Product Licence number to: PL 0425/0571
|
|
Updated on 28/09/2005 and displayed until 10/08/2006
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 28/02/2003 and displayed until 28/09/2005
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 28/08/2001 and displayed until 28/02/2003
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 06/09/1999 and displayed until 28/08/2001
|
Reasons for adding or updating:
|
|
|
|